Press Releases

November 26, 2012 • 9:44 AM EST

Amarantus BioSciences Demands Cessation of Unauthorized Listing on Berlin-Bremen Stock Exchange

November 23, 2012 • 7:30 AM EST

OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals

November 20, 2012 • 9:50 AM EST

Amarantus BioSciences Wins MANF Patent Challenge in Europe

November 19, 2012 • 6:20 AM EST

Amarantus BioSciences Issues CEO Letter to Shareholders

November 15, 2012 • 9:09 AM EST

Amarantus BioSciences to Present at CNS Summit 2012

November 14, 2012 • 2:53 PM EST

Amarantus BioSciences Secures $1.1 Million in Financing

November 12, 2012 • 7:30 AM EST

Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor

November 9, 2012 • 5:42 PM EST

Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release

November 9, 2012 • 9:43 AM EST

Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinson's Blood Test Joint Venture

November 7, 2012 • 7:30 AM EST

Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release